Compare DoorDash Inc (DASH) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DoorDash Inc vs Zimmer Biomet Holdings Inc — how do they compare? DoorDash Inc trades at $211.93 (market cap $91.86B), while Zimmer Biomet Holdings Inc trades at $96.54 (market cap $18.55B). The key difference: DoorDash Inc is far larger — about 5× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays a 0.99% dividend while DoorDash Inc pays none. Which is the better fit depends on your goals.
| DASH | ZBH | |
|---|---|---|
Market Cap | $91.86B | $18.55B |
Sector | Consumer Cyclical | Health |
52-Week High | $281.74 | $107.71 |
52-Week Low | $146.60 | $79.58 |
Enterprise Value | $89.82B | $25.61B |
Dividend Yield | — | 0.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DoorDash (DASH) trades at $214.47, up 2.2% today, with a bullish technical signal from moving averages and strong institutional support. The company reported Q2 2026 revenue of $4.45 billion, up 36% year-over-year, though earnings per share of $0.46 missed estimates. Revenue growth remains robust, with 2025 revenue reaching $13.72 billion and net income turning positive at $935 million, marking sustained GAAP profitability.
The outlook is positive with 75.68% of analysts rating DASH a Buy and a consensus price target of $247.41, suggesting 15% upside. Key risks include elevated valuation multiples, rising R&D costs impacting margins, and competitive pressures in the delivery sector. Growth catalysts include international expansion and AI investments, but profitability sustainability remains a watch point.
ZBH trades at $96.04, down 1.78% today, with a bullish technical signal from moving averages and a consensus analyst price target of $103.56. Recent Q2 2026 earnings beat expectations with EPS of $2.07 versus $2.01 expected, and the company raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23 billion and a net income margin of 8.56%.
The outlook is positive given earnings momentum and raised guidance, but risks include competitive pressures and debt levels, with the debt-to-asset ratio rising to 32.57% in 2025. Analyst sentiment is mixed with 40% buy ratings, offering a potential 7.8% upside to the consensus target, though investors should monitor margin trends and debt management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DoorDash Inc
Founded in 2013 and headquartered in San Francisco, DoorDash is an online food order demand aggregator. Consumers can use its app to order food on-demand for pickup or delivery from merchants mainly in the U.S. The firm provides a marketplace for the merchants to create a presence online, market their offerings, and meet demand by making the offerings available for pickup or delivery. The firm provides similar service to businesses in addition to restaurants, such as grocery, retail, pet supplies, and flowers. At the end of 2020, DoorDash had over 450,000 merchants, 20 million consumers, and over 1 million dashers on its platform. In 2020, the firm generated $24.7 billion in gross order volume (up 207% year over year) and $2.9 billion in revenue (up 226%).
Read more on DASH →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
